Mysterious Stone Secrets in Saudi Arabia Uncovered

Mysterious stone structures known as ‘Mustatil’ in northwestern Saudi Arabia, are among the oldest archeological ruins in the world
Mysterious stone structures known as ‘Mustatil’ in northwestern Saudi Arabia, are among the oldest archeological ruins in the world
TT

Mysterious Stone Secrets in Saudi Arabia Uncovered

Mysterious stone structures known as ‘Mustatil’ in northwestern Saudi Arabia, are among the oldest archeological ruins in the world
Mysterious stone structures known as ‘Mustatil’ in northwestern Saudi Arabia, are among the oldest archeological ruins in the world

KAUST scientists have used deep learning algorithms to accelerate the examination of thousands of years old, giant, stone rectangles in the Saudi desert.

“An international study showed that the huge, mysterious stone structures known as ‘Mustatil’ (Arab word for ‘Rectangle’) in northwestern Saudi Arabia, are among the oldest archeological ruins in the world,” Saudi Minister of Culture, Prince Badr bin Abdullah bin Farhan, said in a tweet in 2021.

These historic sites, which are around 7,000 years old, bewildered researchers and scientists who have long sought to determine their nature and the reasons behind their construction. A recent study by the University of Cambridge suggested that these huge structures, comprising chambers, entrances, and seats, are more complicated than expected.

‘Smart’ archeological survey

For quicker results, researchers at the King Abdullah University of Science and Technology (KAUST) have used an artificial intelligence network to carry out a detailed geological survey in the region, which hasn’t been sufficiently studied so far.

The team is composed of Dr. Silvio Giancola, researcher at KAUST’s Image and Video Understanding Lab (IVUL) and the Artificial Intelligence Initiative; Dr. Laurence Hapiot, archaeological research and cultural outreach fellow at KAUST; and Prof. Bernard Ghanem, IVUL senior researcher, and vice president of the Artificial Intelligence Initiative. The project is funded by the president bureau, dean bureau, and IVUL at KAUST.

AI tools are among the best methods used to assess archaeological sites and process general archaeological data, especially when it comes to spatial analyses such as the view field, which can be highly complicated without computers.

Rectangles of the desert

In 2020, the Saudi Heritage Commission announced that a scientific team discovered stone structures in the Nefud Desert, and identified the discovery as the oldest animal traps in the world, dating to 7,000 years.

According to the commission, the findings confirmed that the northern regions of the kingdom witnessed a cultural evolution in around 5,000 years BC. At the time, inhabitants built hundreds of large, stone constructions, which indicates cultural advancement in the region.

The fieldwork explored the archeological and environmental contexts of the stone constructions, especially the rectangle-shaped structure described as animal traps. These stone rectangles played a similar role and reflected a behavioral evolution that suggests a competition over pastures in complex, unstable environments in the Arabian Peninsula, even in periods of humidity like the Holocene era, during which people struggled with drought.

New research field

Inspired by a new research field known as ‘Computational archaeology’, this initiative used an AI software to model the exploration of stone structures with the help of satellites images.

Computational archaeology uses accurate, computer-based analytical methods including geographical information systems (GIS) to study data on long-term human behavior and behavioral evolution. Over more than a decade, archaeologists used available sources to manually analyze satellite images, and tools like Google Maps to search for possible archaeological sites.

In this project, KAUST’s researchers used automation to scan the unfamiliar, large rectangular stones in the Saudi Nefud Desert, in addition to other archaeological sites of circular and triangular shapes. The approach relies on machine learning algorithms fed with data sorted by Dr. Hapiot. Once the algorithms were trained, scientists became able to filter hundreds of similar characteristics on a wide scale. Now, when archaeologists discover a new structure, they can use the tool to convert similar pixels into geodetic data via GPS, and then combine results in a digital map and database for analysis.

“This demonstrates that KAUST is a unique research facility that excels in different faculties. Few environments can achieve an accelerated integration of deep, technical approaches like Artificial Intelligence in cooperation with archaeologists. This helped reach a different understanding of Nefud’s stone structures,” said Hapiot.

The extensively studied field in Nefud features thousands of massive, stone structures. Given that Saudi Arabia’s area is approximately two million square kilometers, geological surveys using conventional research operations and exploration methods could take months, or maybe years. But the new AI-based approach used by KAUST’s team took only five hours.

Commenting on the modern techniques used in this field, Dr. Jaser Suleiman al-Harbash, executive director of the Saudi Heritage Commission, said: “AI and machine learning processed huge sets of data from the Saudi archeological sites with an amazing speed. The commission hails the efforts made by KAUST to use the latest techniques in studying those ancient, stone structures. This can help us find more about the stones’ function and distribution, as well as the ancient civilization that built them.”

In addition to accelerating archaeological exploration, the new technique could provide answers to many questions about the size, capacity, and distribution of the stones, as well as determining whether exploring an ancient structure in a given region can help find other similar or linked structures in neighboring regions.

Other benefits

The benefits of the new deep learning technique used by KAUST are not limited to exploring archaeologic sites, as they can also help achieve the Vision 2030 goals, by preserving and documenting the unique heritage of Saudi Arabia, and promoting tourism. The new technique can be used in other regions with similar soil characteristics and topography. An initiative should be launched to help enhance the benefits of AI in archaeology, so archaeologists and data scientists can exchange their knowledge and achieve promising results.

Archaeology studies the whole activity of our ancestors in a given place and time. These activities include the tools made by humans to meet basic needs, construction, social and economic behaviors, written texts and architecture, and artistic and scientific works.

Archaeology also focuses on studying the origins of human civilizations, using the latest techniques that analyze the tiniest details related to our ancestors. The second half of the 20th century saw the emergence of the “New Archaeology” term, which indicates studying the organization of human communities in their locations, and defining their social structure in order to connect all these findings in a universal system on human behavior.



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”